Shriya Krishna

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineMaterials ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer”.

HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer

Molecular Imaging and Biology(2022)10.1007/s11307-022-01763-9

N/A

0DataRank · unranked

4 citations

Carolina de Aguiar Ferreira, Nicholas J. Rotile, Bahar Ataeinia, Shriya Krishna, Onofrio A. Catalano +5 more

Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies

Theranostics(2024)10.7150/thno.100116

N/A

0DataRank · unranked

18 citations

Hua Ma, Shriya Krishna, Sergey Shuvaev, Mark F Sabbagh, Caitlin Deffler +21 more

Development of a fibrin-targeted theranostic for gastric cancer

Science Translational Medicine(2024)10.1126/scitranslmed.adn7218

N/A

0DataRank · unranked

4 citations

Li Ma, Shriya Krishna, Hua Ma, Shvan J. Raheem, Sergey Shuvaev +17 more

Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-3548

N/A

0DataRank · unranked

6 citations

Shadi A. Esfahani, Shriya Krishna, Bahar Ataeinia, Iris Y. Zhou, Nicholas J. Rotile +6 more